High risk of essential hypertension in males with intron 4 VNTR polymorphism of eNOS gene

Indian Journal of Human Genetics

Volumn 15, Issue 2, 2009, Pages 49-53

  Patkar, Sushma ^a   Charita, B H ^a   Ramesh, C ^b   Padma, T ^a  

^a OSMANIA UNIVERSITY   (India)

^b GANDHI MEDICAL COLLEGE   (India)

Author keywords

Endothelial NOS gene; Essential hypertension; Polymorphism

Indexed keywords

DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EATING HABIT; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OBESITY; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; VARIABLE NUMBER OF TANDEM REPEAT; VEGETARIAN;

EID: 70249125473     PISSN: 09716866     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0971-6866.55215     Document Type: Article

References (23)

1. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142
2. Wang Y, Marsden PA. Nitric Oxide Synthase: Biochemical and molecular regulation. Curr Opin Nephrol Hypertens 1995;4:12-22.
3. Furlong B, Henderson AH, Lewis MJ, Smith JA. Endothelium- derived relaxing factor inhibits in in vitro platelet aggregation. Br J Pharmacol 1987;90:687-692
4. Yao SK, Ober JC, Krishnaswami A, Ferguson JJ, Anderson V, Golino P, et al. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium injured arteries. Circulation 1992;86:1302-1309
5. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV,Shi XM, et al. Structure and chromosomal localization ofthe human constitutive endothelial nitric oxide synthasegene. J Biol Chem 1993;268:17478-17488
6. Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F. Genestructure, polymorphism and mapping of the humanendothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994;198:1027-1033
7. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, et al. A common Vairant of endothelial nitric oxide synthase (Glu 298-Asp) is a major risk factor for coronary artery disease in UK. Circulation 1999;100:1515-1520
8. Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, Masetti S, et al. Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 2003;49:389-395
9. Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, Jones C, et al. The T-786 C mutatation in endothelial nitric oxide synthase is associatd with hypertension. Hypertension 2002;39:919-922
10. Nakayama M, Yasue H, Yashimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. T786C mutation in the 5′-ß anking region of the endothelial nitric oxide synthase Gene is associated with coronary spasm. Circulation 1999;99:2864-2870
11. Rossi GP, Cesari M, Zanchetta M, Colonna M, Maiolino G, Pedon L, et al. The T 786 C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian Patients of the GENICA study. J Am Coll Cardiol 2003;41:930-937
12. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking dependant risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996;2:41-45
13. Wang Y, Kikuchi K, Suzuki H, Nagase S, Koyama A. Endothelial Nitric Oxide Synthase gene Polymorphism in intron 4 affects the progression of renal failure in Non . diabetic renal diseases. Nephrol Dial Transplant 1999;14:2898-2902
14. Buracznska M, Ksiazek P, Zaluska W, Nowicka T, Ksiazek A. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end stage renal disease. Nephrol Dial Transplant 2004;19:2302-2306
15. Uwabo J, Soma M, Nakayama T, Kanmatsuse K. Association of a Variable Number of tandem repeats in Endotheial Constitutive Nitric Oxide Synthase gene with essential hypertension. Am J Hypertns 1998;11:125-8.
16. Hou L, Osei-Hyiaman D,Yu H, Ren Z, Zhang Z, Wang B, Harada S. Association of a 27 bp repeat polymorphism in eNOS gene with ischemic stroke in Chinese Population. Neurology 2001;56:4.
17. Yen WenWu, Lee C, Hsu S, Lee Y. Association of endothelial nitric oxide synthase polymorphism and the risk of premature coronary artry disease in taiwan. J Inter Med Taiwan 2003;14:1-10.
18. Lahiri DK, Nurnberger JI Jr. I A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
19. Wang J, Dudley D, Wang X L. Haplotype specific effects on endothelial nitric oxide synthase promoter efficiency: Modifiable by cigarette smoking Arteroscler Thromb Vase Biol 2002;22:e1-4.
20. Li R, Lyn D, Lapu-Bula R, Oduwole A, Igho-Pemu P, Lankford B. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function and blood pressure in African Americans. Am J Hypertens 2004;17:560-567
21. Salimi S, Firoozrai M, Nourmohammadi I, Shabani M, Mohebbi A. Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran Indian J Med Res 2006;124:683-688 (Pubitemid 46592109)
22. Ichihara S, Yamada Y, Fujimura T, Nakashima N,Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infraction in the Japanese population. Am J Cardiol 1998;18:83-86
23. Sigusch HH, Suber R, Lehmann MH, Surber S, Weber J, Henke A, et al. Lack of association between 27-bp repeat polymorphism in intron4 of endothelial nitric oxide synthase gene and the risk of coronary disease. Scand J Clin Lab Invest 2002;60:22.